Long-term remission of prostate cancer with extensive bone metastases upon immuno- and virotherapy: A case report
/in Dendritic Cells, Hyperthermia, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus, Prostate Cancer /von 2014-10-06 / Oncol Lett 2014 Dec;8(6):2403-2406Intravenously injected Newcastle disease virus in non-human primates is safe to use for oncolytic virotherapy
/in International Publications, Newcastle Disease Virus /von 2014-09-26 / Cancer Gene Ther. 2014 Nov;21(11):463-71Effect of recombinant Newcastle disease virus transfection on lung adenocarcinoma A549 cells
/in International Publications, Newcastle Disease Virus, NSCLC /von 2014-09-25 / Oncol Lett 2014 Dec;8(6):2569-2576Newcastle disease virotherapy induces long-term survival and tumor-specific immune memory in orthotopic glioma through the induction of immunogenic cell death
/in Glioblastoma, Immunogenic Cell Death, International Publications, Newcastle Disease Virus /von 2014-09-19 / Int J Cancer 2015 Mar;136(5):E313-25Immunomodulatory effects of Newcastle disease virus AF2240 strain on human peripheral blood mononuclear cells
/in International Publications, Newcastle Disease Virus /von 2014-09-19 / Int J Med Sci 2014;11(12):1240-7Multimodal cancer therapy involving oncolytic newcastle disease virus, autologous immune cells, and bi-specific antibodies
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2014-09-11 / Front Oncol 2014;4:224Newcastle disease virus interaction in targeted therapy against proliferation and invasion pathways of glioblastoma multiforme
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 2014-08-27 / Biomed Res Int 2014;2014:386470Mitophagy promotes replication of oncolytic Newcastle disease virus by blocking intrinsic apoptosis in lung cancer cells
/in International Publications, Newcastle Disease Virus /von 2014-08-15 / Oncotarget 2014 Aug;5(15):6365-74Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines
/in International Publications, Newcastle Disease Virus /von 2014-08-12 / Front Oncol 2014;4:217
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution